How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Sebia in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
32 clearance records and 0 recall records in the covered releases, across 1 source company names and 12 product codes. Dated history runs from Jun 30, 1995 to Apr 4, 2024.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| CAPI 3 NEONAT Hb, CAPILLARYS 3 DBS InstrumentK232027 · GKA | Sebia | 510(k) | Apr 4, 2024FDA decision date |
| FLC Kappa, FLC Lambda,FLC Control Level 1, FLC Control Level 2K231601 · DFH | Sebia | 510(k) | Feb 23, 2024FDA decision date |
| FLC Kappa, FLC Lambda, FLC Control Level 1, FLC Control Level 2K210623 · DFH | Sebia | 510(k) | Nov 18, 2022FDA decision date |
| HYDRASHIFT 2/4 isatuximabK203184 · CFF | Sebia | 510(k) | Nov 12, 2021FDA decision date |
| CAPI 3 Immunotyping, Capillarys 3 TeraK192095 · CFF | Sebia | 510(k) | Nov 1, 2019FDA decision date |
| HYDRASHIFT 2/4 daratumumabK190851 · CFF | Sebia | 510(k) | May 2, 2019FDA decision date |
| CAPI 3 HEMOGLOBIN(E)K180762 · GKA | Sebia | 510(k) | Dec 14, 2018FDA decision date |
| CAPILLARYS Hb A1cK171861 · PDJ | Sebia | 510(k) | Feb 7, 2018FDA decision date |
| HYDRASHIFT 2/4 daratumumab, daratumumab ControlK172195 · CFF | Sebia | 510(k) | Jan 11, 2018FDA decision date |
| CAPI 3 Hb A1cK171537 · PDJ | Sebia | 510(k) | Sep 12, 2017FDA decision date |
| CAPI 3 Hb A1c, MULTI-SYSTEM Hb A1C CAPILLARY CONTROLS (2)K162281 · LCP | Sebia | 510(k) | Feb 17, 2017FDA decision date |
| CAPI 3 IMMUNOTYPING, CAPILLARYS 3 TERA, IT/IF CONTROLK161928 · CFF | Sebia | 510(k) | Dec 21, 2016FDA decision date |
| MINICAP Immunotyping using the MINICAP and the MINICAP FLEX-PIERCINGK143483 · CFF | Sebia | 510(k) | Jan 8, 2015FDA decision date |
| MINICAP HB A1C, MINICAP FLEX-PIERCING, HB A1C CAPILLARYS CONTROLS, HBA1C CAPILLARYS CALIBRATORSK133344 · LCP | Sebia | 510(k) | Mar 28, 2014FDA decision date |
| CAPILLARYS IMMUNOTYPING, CAPILLARYS 2 INSTRUMENT, IT/IF CONTROL, CAPILLARYS 2 FLEX PIERCING INSTRUMENTK130500 · CEF | Sebia | 510(k) | Jul 26, 2013FDA decision date |
| CAPILLARYS HEMOGLOBIN HBA1C CAPILLARYS 2 FLEX PIERCING CAPILLARYS HBA1C CONTROLS CAPILLARYS HBA1C CK122101 · LCP | Sebia | 510(k) | Dec 6, 2012FDA decision date |
| CAPILLARYS HEMOGLOBIN, CAPILLARYS FLEX PIERCING SYSTEMK112550 · GKA | Sebia | 510(k) | May 25, 2012FDA decision date |
| SEBIA CAPILLARYS HEMOGLOBIN(E) WITH CAPILLARYS 2K112491 · GKA | Sebia | 510(k) | May 24, 2012FDA decision date |
| IT/IF CONTROLK101863 · JJY | Sebia | 510(k) | Nov 7, 2011FDA decision date |
| GELSCAN, MODEL 1206K100307 · CFE | Sebia | 510(k) | Aug 31, 2010FDA decision date |
| CAPILLARYS NEONAT HB (PN 2006)K091283 · GKA | Sebia | 510(k) | Feb 22, 2010FDA decision date |
| CAPILLARYS IMMUNOTYPING, MODEL 2100K082085 · CFF | Sebia | 510(k) | Apr 17, 2009FDA decision date |
| MINICAP IMMUNOTYPING, MODEL: 2300K082388 · CFF | Sebia | 510(k) | Apr 14, 2009FDA decision date |
| MINICAP HEMOGLOBIN(E) KIT, MODEL 2207, 2227K082227 · GKA | Sebia | 510(k) | Mar 26, 2009FDA decision date |
| CAPILLARYS URINEK080916 · JKM | Sebia | 510(k) | Jul 1, 2008FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.